Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | ABCB11 CL E G H | 8647 | 42 | ORPHA:69665 | Intrahepatic cholestasis of pregnancy | | | | 146 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | ABCB4 CL E G H | 5244 | 45 | OMIM:614972 | Cholestasis, intrahepatic, of pregnancy 3 | | | | 111 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | ABCB4 CL E G H | 5244 | 45 | ORPHA:69665 | Intrahepatic cholestasis of pregnancy | | | | 111 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | ABCD3 CL E G H | 5825 | 67 | OMIM:616278 | BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5; CBAS5 | | | | 5 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | ABCD4 CL E G H | 5826 | 68 | OMIM:614857 | Methylmalonic aciduria and homocystinuria, Cblj type | | | | 53 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | ACAD8 CL E G H | 27034 | 87 | ORPHA:79159 | Isobutyryl-CoA dehydrogenase deficiency | | | | 58 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | ACAD8 CL E G H | 27034 | 87 | OMIM:611283 | Isobutyryl-CoA dehydrogenase deficiency | | | | 58 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | ACAD9 CL E G H | 28976 | 21497 | ORPHA:99901 | Acyl-CoA dehydrogenase 9 deficiency | | | | 98 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | ACADM CL E G H | 34 | 89 | OMIM:201450 | Acyl-Coa dehydrogenase, medium-chain, deficiency of | | | | 197 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | ACADM CL E G H | 34 | 89 | ORPHA:42 | Medium chain acyl-CoA dehydrogenase deficiency | | | | 197 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | ACADS CL E G H | 35 | 90 | ORPHA:26792 | Short chain acyl-CoA dehydrogenase deficiency | | | | 90 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | ACADVL CL E G H | 37 | 92 | OMIM:201475 | Very long-chain acyl-CoA dehydrogenase deficiency | | | | 200 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | AKR1D1 CL E G H | 6718 | 388 | ORPHA:79303 | Congenital bile acid synthesis defect type 2 | | | | 62 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | AP1B1 CL E G H | 162 | 554 | OMIM:242150 | Ichthyosiform erythroderma, corneal involvement, and deafness | | | | | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | ATP8B1 CL E G H | 5205 | 3706 | OMIM:243300 | Cholestasis, benign recurrent intrahepatic 1 | | | | 144 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | ATP8B1 CL E G H | 5205 | 3706 | OMIM:147480 | Cholestasis, intrahepatic, of pregnancy, 1 | | | | 144 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | ATP8B1 CL E G H | 5205 | 3706 | ORPHA:69665 | Intrahepatic cholestasis of pregnancy | | | | 144 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | COL7A1 CL E G H | 1294 | 2214 | ORPHA:89842 | Autosomal recessive generalized dystrophic epidermolysis bullosa, intermediate form | | | | 263 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | COL7A1 CL E G H | 1294 | 2214 | ORPHA:79408 | Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form | | | | 263 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | COX16 CL E G H | 51241 | 20213 | OMIM:619355 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 22; MC4DN22 | | | | | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | CPT2 CL E G H | 1376 | 2330 | ORPHA:228302 | Carnitine palmitoyl transferase II deficiency, myopathic form | | | | 101 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | CPT2 CL E G H | 1376 | 2330 | ORPHA:228308 | Carnitine palmitoyl transferase II deficiency, neonatal form | | | | 101 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | CPT2 CL E G H | 1376 | 2330 | ORPHA:228305 | Carnitine palmitoyl transferase II deficiency, severe infantile form | | | | 101 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | CPT2 CL E G H | 1376 | 2330 | OMIM:608836 | Carnitine palmitoyltransferase II deficiency, lethal neonatal | | | | 101 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | CTNS CL E G H | 1497 | 2518 | OMIM:219800 | Cystinosis, nephropathic | | | | 178 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | DLD CL E G H | 1738 | 2898 | ORPHA:2394 | Pyruvate dehydrogenase E3 deficiency | | | | 89 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | DNAJC21 CL E G H | 134218 | 27030 | ORPHA:811 | Shwachman-Diamond syndrome | | | | 5 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | DNM1L CL E G H | 10059 | 2973 | OMIM:614388 | Encephalopathy due to defective mitochondrial and peroxisomal fission 1 | | | | 94 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | DZIP1L CL E G H | 199221 | 26551 | ORPHA:731 | Autosomal recessive polycystic kidney disease | | | | 4 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | EFL1 CL E G H | 79631 | 25789 | ORPHA:811 | Shwachman-Diamond syndrome | | | | 1 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | EHHADH CL E G H | 1962 | 3247 | ORPHA:3337 | Primary Fanconi renotubular syndrome | | | | 2 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | ETHE1 CL E G H | 23474 | 23287 | OMIM:602473 | Encephalopathy, ethylmalonic | | | | 42 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | GATM CL E G H | 2628 | 4175 | ORPHA:3337 | Primary Fanconi renotubular syndrome | | | | 86 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | HADH CL E G H | 3033 | 4799 | ORPHA:71212 | Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency | | | | 41 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | HADHA CL E G H | 3030 | 4801 | OMIM:609015 | Mitochondrial trifunctional protein deficiency | | | | 99 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | HADHB CL E G H | 3032 | 4803 | OMIM:609015 | Mitochondrial trifunctional protein deficiency | | | | 60 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | HMGCL CL E G H | 3155 | 5005 | OMIM:246450 | 3-Hydroxy-3-Methylglutaryl-Coa lyase deficiency | | | | 35 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | KIF12 CL E G H | 113220 | 21495 | OMIM:619662 | CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 8; PFIC8 | | | | 1 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | LMBRD1 CL E G H | 55788 | 23038 | ORPHA:79284 | Methylmalonic acidemia with homocystinuria type cblF | | | | 46 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | LMBRD1 CL E G H | 55788 | 23038 | OMIM:277380 | Methylmalonic aciduria and homocystinuria, Cblf type | | | | 46 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | MCCC2 CL E G H | 64087 | 6937 | OMIM:210210 | 3-Methylcrotonyl-CoA carboxylase 2 deficiency | | | | 77 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | MCEE CL E G H | 84693 | 16732 | OMIM:251120 | Methylmalonyl-Coa epimerase deficiency | | | | 19 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | MMACHC CL E G H | 25974 | 24525 | ORPHA:79282 | Methylmalonic acidemia with homocystinuria, type cblC | | | | 101 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | MMP1 CL E G H | 4312 | 7155 | ORPHA:79408 | Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form | | | | 6 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | MYO5B CL E G H | 4645 | 7603 | OMIM:619868 | | | | | 192 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | NADK2 CL E G H | 133686 | 26404 | OMIM:616034 | 2,4-Dienoyl-Coa reductase deficiency | | | | 14 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | NADK2 CL E G H | 133686 | 26404 | ORPHA:431361 | Progressive encephalopathy with leukodystrophy due to DECR deficiency | | | | 14 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | NDUFAF6 CL E G H | 137682 | 28625 | ORPHA:3337 | Primary Fanconi renotubular syndrome | | | | 39 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | NFU1 CL E G H | 27247 | 16287 | OMIM:605711 | Multiple mitochondrial dysfunctions syndrome 1 | | | | 34 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | NR1H4 CL E G H | 9971 | 7967 | ORPHA:69665 | Intrahepatic cholestasis of pregnancy | | | | 14 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | PEX26 CL E G H | 55670 | 22965 | OMIM:614872 | Peroxisome biogenesis disorder 7A (zellweger) | | | | 106 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | PKHD1 CL E G H | 5314 | 9016 | ORPHA:731 | Autosomal recessive polycystic kidney disease | | | | 563 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | SBDS CL E G H | 51119 | 19440 | ORPHA:811 | Shwachman-Diamond syndrome | | | | 26 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | SCO1 CL E G H | 6341 | 10603 | OMIM:619048 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 4; MC4DN4 | | | | 46 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | SEMA7A CL E G H | 8482 | 10741 | OMIM:619874 | | | | | 5 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | SLC10A1 CL E G H | 6554 | 10905 | OMIM:619256 | HYPERCHOLANEMIA, FAMILIAL, 2; FHCA2 | | | | | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | SLC22A5 CL E G H | 6584 | 10969 | OMIM:212140 | Carnitine deficiency, systemic primary | | | | 207 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | SLC25A20 CL E G H | 788 | 1421 | ORPHA:159 | Carnitine-acylcarnitine translocase deficiency | | | | 40 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | SLC34A1 CL E G H | 6569 | 11019 | ORPHA:3337 | Primary Fanconi renotubular syndrome | | | | 47 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | SLC51B CL E G H | 123264 | 29956 | OMIM:619481 | BILE ACID MALABSORPTION, PRIMARY, 2; PBAM2 | | | | | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | SLC52A1 CL E G H | 55065 | 30225 | OMIM:615026 | Riboflavin deficiency | | | | 3 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | SRP54 CL E G H | 6729 | 11301 | ORPHA:811 | Shwachman-Diamond syndrome | | | | | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | TALDO1 CL E G H | 6888 | 11559 | ORPHA:101028 | Transaldolase deficiency | | | | 34 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | TANGO2 CL E G H | 128989 | 25439 | OMIM:616878 | Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration | | | | 12 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | TANGO2 CL E G H | 128989 | 25439 | ORPHA:480864 | Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome | | | | 12 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | TJP2 CL E G H | 9414 | 11828 | OMIM:607748 | Hypercholanemia, familial | | | | 149 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | TRMU CL E G H | 55687 | 25481 | ORPHA:254864 | Mitochondrial myopathy with reversible cytochrome C oxidase deficiency | | | | 101 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | TRNE CL E G H | 4556 | 7479 | ORPHA:254864 | Mitochondrial myopathy with reversible cytochrome C oxidase deficiency | | | | | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | UNC45A CL E G H | 55898 | 30594 | OMIM:619377 | OSTEOOTOHEPATOENTERIC SYNDROME; OOHE | | | | | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | VPS33B CL E G H | 26276 | 12712 | OMIM:620010 | | | | | 63 | | |
HP:0010996 | HP:0010996 | Abnormal circulating monocarboxylic acid concentration | 0 | VPS50 CL E G H | 55610 | 25956 | OMIM:619685 | NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND NEONATAL CHOLESTASIS; NEDMSC | | | | | | |
HP:0010996 | HP:0410154 | Increased level of myristic acid in serum | 1 | CL E G H | | | | | | | | | | |
HP:0010996 | HP:0033324 | Elevated circulating homovanillic acid concentration | 1 | CL E G H | | | | | | | | | | |
HP:0010996 | HP:0033302 | Elevated circulating 4-hydroxyphenylacetic acid concentration | 1 | CL E G H | | | | | | | | | | |
HP:0010996 | HP:0025641 | Elevated circulating glycolate concentration | 1 | CL E G H | | | | | | | | | | |
HP:0010996 | HP:0033435 | Abnormal circulating keto acid concentration | 1 | CL E G H | | | | | | | | | | |
HP:0010996 | HP:0030984 | Abnormal serum bile acid concentration | 1 | ABCB11 CL E G H | 8647 | 42 | ORPHA:69665 | Intrahepatic cholestasis of pregnancy | | | | 146 | | |
HP:0010996 | HP:0030984 | Abnormal serum bile acid concentration | 1 | ABCB4 CL E G H | 5244 | 45 | OMIM:614972 | Cholestasis, intrahepatic, of pregnancy 3 | | | | 111 | | |
HP:0010996 | HP:0030984 | Abnormal serum bile acid concentration | 1 | ABCB4 CL E G H | 5244 | 45 | ORPHA:69665 | Intrahepatic cholestasis of pregnancy | | | | 111 | | |
HP:0010996 | HP:0030984 | Abnormal serum bile acid concentration | 1 | ABCD3 CL E G H | 5825 | 67 | OMIM:616278 | BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5; CBAS5 | | | | 5 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | ABCD4 CL E G H | 5826 | 68 | OMIM:614857 | Methylmalonic aciduria and homocystinuria, Cblj type | | | | 53 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | ACAD8 CL E G H | 27034 | 87 | OMIM:611283 | Isobutyryl-CoA dehydrogenase deficiency | | | | 58 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | ACAD8 CL E G H | 27034 | 87 | ORPHA:79159 | Isobutyryl-CoA dehydrogenase deficiency | | | | 58 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | ACAD9 CL E G H | 28976 | 21497 | ORPHA:99901 | Acyl-CoA dehydrogenase 9 deficiency | | | | 98 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | ACADM CL E G H | 34 | 89 | OMIM:201450 | Acyl-Coa dehydrogenase, medium-chain, deficiency of | | | | 197 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | ACADM CL E G H | 34 | 89 | ORPHA:42 | Medium chain acyl-CoA dehydrogenase deficiency | | | | 197 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | ACADS CL E G H | 35 | 90 | ORPHA:26792 | Short chain acyl-CoA dehydrogenase deficiency | | | | 90 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | ACADVL CL E G H | 37 | 92 | OMIM:201475 | Very long-chain acyl-CoA dehydrogenase deficiency | | | | 200 | | |
HP:0010996 | HP:0030984 | Abnormal serum bile acid concentration | 1 | AKR1D1 CL E G H | 6718 | 388 | ORPHA:79303 | Congenital bile acid synthesis defect type 2 | | | | 62 | | |
HP:0010996 | HP:0030984 | Abnormal serum bile acid concentration | 1 | AP1B1 CL E G H | 162 | 554 | OMIM:242150 | Ichthyosiform erythroderma, corneal involvement, and deafness | | | | | | |
HP:0010996 | HP:0030984 | Abnormal serum bile acid concentration | 1 | ATP8B1 CL E G H | 5205 | 3706 | OMIM:243300 | Cholestasis, benign recurrent intrahepatic 1 | | | | 144 | | |
HP:0010996 | HP:0030984 | Abnormal serum bile acid concentration | 1 | ATP8B1 CL E G H | 5205 | 3706 | OMIM:147480 | Cholestasis, intrahepatic, of pregnancy, 1 | | | | 144 | | |
HP:0010996 | HP:0030984 | Abnormal serum bile acid concentration | 1 | ATP8B1 CL E G H | 5205 | 3706 | ORPHA:69665 | Intrahepatic cholestasis of pregnancy | | | | 144 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | COL7A1 CL E G H | 1294 | 2214 | ORPHA:89842 | Autosomal recessive generalized dystrophic epidermolysis bullosa, intermediate form | | | | 263 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | COL7A1 CL E G H | 1294 | 2214 | ORPHA:79408 | Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form | | | | 263 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | COX16 CL E G H | 51241 | 20213 | OMIM:619355 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 22; MC4DN22 | | | | | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | CPT2 CL E G H | 1376 | 2330 | ORPHA:228302 | Carnitine palmitoyl transferase II deficiency, myopathic form | | | | 101 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | CPT2 CL E G H | 1376 | 2330 | ORPHA:228308 | Carnitine palmitoyl transferase II deficiency, neonatal form | | | | 101 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | CPT2 CL E G H | 1376 | 2330 | ORPHA:228305 | Carnitine palmitoyl transferase II deficiency, severe infantile form | | | | 101 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | CPT2 CL E G H | 1376 | 2330 | OMIM:608836 | Carnitine palmitoyltransferase II deficiency, lethal neonatal | | | | 101 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | CTNS CL E G H | 1497 | 2518 | OMIM:219800 | Cystinosis, nephropathic | | | | 178 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | DLD CL E G H | 1738 | 2898 | ORPHA:2394 | Pyruvate dehydrogenase E3 deficiency | | | | 89 | | |
HP:0010996 | HP:0030984 | Abnormal serum bile acid concentration | 1 | DNAJC21 CL E G H | 134218 | 27030 | ORPHA:811 | Shwachman-Diamond syndrome | | | | 5 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | DNM1L CL E G H | 10059 | 2973 | OMIM:614388 | Encephalopathy due to defective mitochondrial and peroxisomal fission 1 | | | | 94 | | |
HP:0010996 | HP:0030984 | Abnormal serum bile acid concentration | 1 | DZIP1L CL E G H | 199221 | 26551 | ORPHA:731 | Autosomal recessive polycystic kidney disease | | | | 4 | | |
HP:0010996 | HP:0030984 | Abnormal serum bile acid concentration | 1 | EFL1 CL E G H | 79631 | 25789 | ORPHA:811 | Shwachman-Diamond syndrome | | | | 1 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | EHHADH CL E G H | 1962 | 3247 | ORPHA:3337 | Primary Fanconi renotubular syndrome | | | | 2 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | ETHE1 CL E G H | 23474 | 23287 | OMIM:602473 | Encephalopathy, ethylmalonic | | | | 42 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | GATM CL E G H | 2628 | 4175 | ORPHA:3337 | Primary Fanconi renotubular syndrome | | | | 86 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | HADH CL E G H | 3033 | 4799 | ORPHA:71212 | Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency | | | | 41 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | HADHA CL E G H | 3030 | 4801 | OMIM:609015 | Mitochondrial trifunctional protein deficiency | | | | 99 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | HADHB CL E G H | 3032 | 4803 | OMIM:609015 | Mitochondrial trifunctional protein deficiency | | | | 60 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | HMGCL CL E G H | 3155 | 5005 | OMIM:246450 | 3-Hydroxy-3-Methylglutaryl-Coa lyase deficiency | | | | 35 | | |
HP:0010996 | HP:0030984 | Abnormal serum bile acid concentration | 1 | KIF12 CL E G H | 113220 | 21495 | OMIM:619662 | CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 8; PFIC8 | | | | 1 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | LMBRD1 CL E G H | 55788 | 23038 | ORPHA:79284 | Methylmalonic acidemia with homocystinuria type cblF | | | | 46 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | LMBRD1 CL E G H | 55788 | 23038 | OMIM:277380 | Methylmalonic aciduria and homocystinuria, Cblf type | | | | 46 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | MCCC2 CL E G H | 64087 | 6937 | OMIM:210210 | 3-Methylcrotonyl-CoA carboxylase 2 deficiency | | | | 77 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | MCEE CL E G H | 84693 | 16732 | OMIM:251120 | Methylmalonyl-Coa epimerase deficiency | | | | 19 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | MMACHC CL E G H | 25974 | 24525 | ORPHA:79282 | Methylmalonic acidemia with homocystinuria, type cblC | | | | 101 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | MMP1 CL E G H | 4312 | 7155 | ORPHA:79408 | Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form | | | | 6 | | |
HP:0010996 | HP:0030984 | Abnormal serum bile acid concentration | 1 | MYO5B CL E G H | 4645 | 7603 | OMIM:619868 | | | | | 192 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | NADK2 CL E G H | 133686 | 26404 | OMIM:616034 | 2,4-Dienoyl-Coa reductase deficiency | | | | 14 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | NADK2 CL E G H | 133686 | 26404 | ORPHA:431361 | Progressive encephalopathy with leukodystrophy due to DECR deficiency | | | | 14 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | NDUFAF6 CL E G H | 137682 | 28625 | ORPHA:3337 | Primary Fanconi renotubular syndrome | | | | 39 | | |
HP:0010996 | HP:0033417 | Elevated circulating hydroxybutyric acid concentration | 1 | NFU1 CL E G H | 27247 | 16287 | OMIM:605711 | Multiple mitochondrial dysfunctions syndrome 1 | | | | 34 | | |
HP:0010996 | HP:0030984 | Abnormal serum bile acid concentration | 1 | NR1H4 CL E G H | 9971 | 7967 | ORPHA:69665 | Intrahepatic cholestasis of pregnancy | | | | 14 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | PEX26 CL E G H | 55670 | 22965 | OMIM:614872 | Peroxisome biogenesis disorder 7A (zellweger) | | | | 106 | | |
HP:0010996 | HP:0030984 | Abnormal serum bile acid concentration | 1 | PKHD1 CL E G H | 5314 | 9016 | ORPHA:731 | Autosomal recessive polycystic kidney disease | | | | 563 | | |
HP:0010996 | HP:0030984 | Abnormal serum bile acid concentration | 1 | SBDS CL E G H | 51119 | 19440 | ORPHA:811 | Shwachman-Diamond syndrome | | | | 26 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | SCO1 CL E G H | 6341 | 10603 | OMIM:619048 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 4; MC4DN4 | | | | 46 | | |
HP:0010996 | HP:0030984 | Abnormal serum bile acid concentration | 1 | SEMA7A CL E G H | 8482 | 10741 | OMIM:619874 | | | | | 5 | | |
HP:0010996 | HP:0030984 | Abnormal serum bile acid concentration | 1 | SLC10A1 CL E G H | 6554 | 10905 | OMIM:619256 | HYPERCHOLANEMIA, FAMILIAL, 2; FHCA2 | | | | | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | SLC22A5 CL E G H | 6584 | 10969 | OMIM:212140 | Carnitine deficiency, systemic primary | | | | 207 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | SLC25A20 CL E G H | 788 | 1421 | ORPHA:159 | Carnitine-acylcarnitine translocase deficiency | | | | 40 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | SLC34A1 CL E G H | 6569 | 11019 | ORPHA:3337 | Primary Fanconi renotubular syndrome | | | | 47 | | |
HP:0010996 | HP:0030984 | Abnormal serum bile acid concentration | 1 | SLC51B CL E G H | 123264 | 29956 | OMIM:619481 | BILE ACID MALABSORPTION, PRIMARY, 2; PBAM2 | | | | | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | SLC52A1 CL E G H | 55065 | 30225 | OMIM:615026 | Riboflavin deficiency | | | | 3 | | |
HP:0010996 | HP:0030984 | Abnormal serum bile acid concentration | 1 | SRP54 CL E G H | 6729 | 11301 | ORPHA:811 | Shwachman-Diamond syndrome | | | | | | |
HP:0010996 | HP:0030984 | Abnormal serum bile acid concentration | 1 | TALDO1 CL E G H | 6888 | 11559 | ORPHA:101028 | Transaldolase deficiency | | | | 34 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | TANGO2 CL E G H | 128989 | 25439 | OMIM:616878 | Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration | | | | 12 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | TANGO2 CL E G H | 128989 | 25439 | ORPHA:480864 | Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome | | | | 12 | | |
HP:0010996 | HP:0030984 | Abnormal serum bile acid concentration | 1 | TJP2 CL E G H | 9414 | 11828 | OMIM:607748 | Hypercholanemia, familial | | | | 149 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | TRMU CL E G H | 55687 | 25481 | ORPHA:254864 | Mitochondrial myopathy with reversible cytochrome C oxidase deficiency | | | | 101 | | |
HP:0010996 | HP:0010966 | Abnormal circulating fatty-acid anion concentration | 1 | TRNE CL E G H | 4556 | 7479 | ORPHA:254864 | Mitochondrial myopathy with reversible cytochrome C oxidase deficiency | | | | | | |
HP:0010996 | HP:0030984 | Abnormal serum bile acid concentration | 1 | UNC45A CL E G H | 55898 | 30594 | OMIM:619377 | OSTEOOTOHEPATOENTERIC SYNDROME; OOHE | | | | | | |
HP:0010996 | HP:0030984 | Abnormal serum bile acid concentration | 1 | VPS33B CL E G H | 26276 | 12712 | OMIM:620010 | | | | | 63 | | |
HP:0010996 | HP:0030984 | Abnormal serum bile acid concentration | 1 | VPS50 CL E G H | 55610 | 25956 | OMIM:619685 | NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND NEONATAL CHOLESTASIS; NEDMSC | | | | | | |
HP:0010996 | HP:0033437 | Elevated circulating 4-methyl-2-oxopentanoic acid concentration | 2 | CL E G H | | | | | | | | | | |
HP:0010996 | HP:0033436 | Elevated circulating 3-methyl-2-oxovaleric acid concentration | 2 | CL E G H | | | | | | | | | | |
HP:0010996 | HP:0033419 | Elevated circulating 3-hydroxybutyric acid concentration | 2 | CL E G H | | | | | | | | | | |
HP:0010996 | HP:0012202 | Increased serum bile acid concentration | 2 | ABCB11 CL E G H | 8647 | 42 | ORPHA:69665 | Intrahepatic cholestasis of pregnancy | HP:0040281 - Very frequent | | | 146 | | |
HP:0010996 | HP:0012202 | Increased serum bile acid concentration | 2 | ABCB4 CL E G H | 5244 | 45 | OMIM:614972 | Cholestasis, intrahepatic, of pregnancy 3 | | | | 111 | | |
HP:0010996 | HP:0012202 | Increased serum bile acid concentration | 2 | ABCB4 CL E G H | 5244 | 45 | ORPHA:69665 | Intrahepatic cholestasis of pregnancy | HP:0040281 - Very frequent | | | 111 | | |
HP:0010996 | HP:0012202 | Increased serum bile acid concentration | 2 | ABCD3 CL E G H | 5825 | 67 | OMIM:616278 | BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5; CBAS5 | | | | 5 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | ABCD4 CL E G H | 5826 | 68 | OMIM:614857 | Methylmalonic aciduria and homocystinuria, Cblj type | | | | 53 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | ACAD8 CL E G H | 27034 | 87 | OMIM:611283 | Isobutyryl-CoA dehydrogenase deficiency | | | | 58 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | ACAD8 CL E G H | 27034 | 87 | ORPHA:79159 | Isobutyryl-CoA dehydrogenase deficiency | | | | 58 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | ACAD9 CL E G H | 28976 | 21497 | ORPHA:99901 | Acyl-CoA dehydrogenase 9 deficiency | | | | 98 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | ACADM CL E G H | 34 | 89 | OMIM:201450 | Acyl-Coa dehydrogenase, medium-chain, deficiency of | | | | 197 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | ACADM CL E G H | 34 | 89 | ORPHA:42 | Medium chain acyl-CoA dehydrogenase deficiency | | | | 197 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | ACADS CL E G H | 35 | 90 | ORPHA:26792 | Short chain acyl-CoA dehydrogenase deficiency | | | | 90 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | ACADVL CL E G H | 37 | 92 | OMIM:201475 | Very long-chain acyl-CoA dehydrogenase deficiency | | | | 200 | | |
HP:0010996 | HP:0012202 | Increased serum bile acid concentration | 2 | AP1B1 CL E G H | 162 | 554 | OMIM:242150 | Ichthyosiform erythroderma, corneal involvement, and deafness | | | | | | |
HP:0010996 | HP:0012202 | Increased serum bile acid concentration | 2 | ATP8B1 CL E G H | 5205 | 3706 | OMIM:243300 | Cholestasis, benign recurrent intrahepatic 1 | . | | | 144 | | |
HP:0010996 | HP:0012202 | Increased serum bile acid concentration | 2 | ATP8B1 CL E G H | 5205 | 3706 | OMIM:147480 | Cholestasis, intrahepatic, of pregnancy, 1 | | | | 144 | | |
HP:0010996 | HP:0012202 | Increased serum bile acid concentration | 2 | ATP8B1 CL E G H | 5205 | 3706 | ORPHA:69665 | Intrahepatic cholestasis of pregnancy | HP:0040281 - Very frequent | | | 144 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | COL7A1 CL E G H | 1294 | 2214 | ORPHA:89842 | Autosomal recessive generalized dystrophic epidermolysis bullosa, intermediate form | | | | 263 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | COL7A1 CL E G H | 1294 | 2214 | ORPHA:79408 | Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form | | | | 263 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | COX16 CL E G H | 51241 | 20213 | OMIM:619355 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 22; MC4DN22 | | | | | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | CPT2 CL E G H | 1376 | 2330 | ORPHA:228302 | Carnitine palmitoyl transferase II deficiency, myopathic form | | | | 101 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | CPT2 CL E G H | 1376 | 2330 | ORPHA:228308 | Carnitine palmitoyl transferase II deficiency, neonatal form | | | | 101 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | CPT2 CL E G H | 1376 | 2330 | ORPHA:228305 | Carnitine palmitoyl transferase II deficiency, severe infantile form | | | | 101 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | CPT2 CL E G H | 1376 | 2330 | OMIM:608836 | Carnitine palmitoyltransferase II deficiency, lethal neonatal | | | | 101 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | CTNS CL E G H | 1497 | 2518 | OMIM:219800 | Cystinosis, nephropathic | | | | 178 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | DLD CL E G H | 1738 | 2898 | ORPHA:2394 | Pyruvate dehydrogenase E3 deficiency | | | | 89 | | |
HP:0010996 | HP:0012202 | Increased serum bile acid concentration | 2 | DNAJC21 CL E G H | 134218 | 27030 | ORPHA:811 | Shwachman-Diamond syndrome | HP:0040282 - Frequent | | | 5 | | |
HP:0010996 | HP:0034298 | Elevated circulating hexacosanoic acid concentration | 2 | DNM1L CL E G H | 10059 | 2973 | OMIM:614388 | Encephalopathy due to defective mitochondrial and peroxisomal fission 1 | | | | 94 | | |
HP:0010996 | HP:0012202 | Increased serum bile acid concentration | 2 | DZIP1L CL E G H | 199221 | 26551 | ORPHA:731 | Autosomal recessive polycystic kidney disease | HP:0040282 - Frequent | | | 4 | | |
HP:0010996 | HP:0012202 | Increased serum bile acid concentration | 2 | EFL1 CL E G H | 79631 | 25789 | ORPHA:811 | Shwachman-Diamond syndrome | HP:0040282 - Frequent | | | 1 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | EHHADH CL E G H | 1962 | 3247 | ORPHA:3337 | Primary Fanconi renotubular syndrome | | | | 2 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | ETHE1 CL E G H | 23474 | 23287 | OMIM:602473 | Encephalopathy, ethylmalonic | | | | 42 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | GATM CL E G H | 2628 | 4175 | ORPHA:3337 | Primary Fanconi renotubular syndrome | | | | 86 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | HADH CL E G H | 3033 | 4799 | ORPHA:71212 | Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency | | | | 41 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | HADHA CL E G H | 3030 | 4801 | OMIM:609015 | Mitochondrial trifunctional protein deficiency | | | | 99 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | HADHB CL E G H | 3032 | 4803 | OMIM:609015 | Mitochondrial trifunctional protein deficiency | | | | 60 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | HMGCL CL E G H | 3155 | 5005 | OMIM:246450 | 3-Hydroxy-3-Methylglutaryl-Coa lyase deficiency | | | | 35 | | |
HP:0010996 | HP:0012202 | Increased serum bile acid concentration | 2 | KIF12 CL E G H | 113220 | 21495 | OMIM:619662 | CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 8; PFIC8 | | | | 1 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | LMBRD1 CL E G H | 55788 | 23038 | ORPHA:79284 | Methylmalonic acidemia with homocystinuria type cblF | | | | 46 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | LMBRD1 CL E G H | 55788 | 23038 | OMIM:277380 | Methylmalonic aciduria and homocystinuria, Cblf type | | | | 46 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | MCCC2 CL E G H | 64087 | 6937 | OMIM:210210 | 3-Methylcrotonyl-CoA carboxylase 2 deficiency | | | | 77 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | MCEE CL E G H | 84693 | 16732 | OMIM:251120 | Methylmalonyl-Coa epimerase deficiency | | | | 19 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | MMACHC CL E G H | 25974 | 24525 | ORPHA:79282 | Methylmalonic acidemia with homocystinuria, type cblC | | | | 101 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | MMP1 CL E G H | 4312 | 7155 | ORPHA:79408 | Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form | | | | 6 | | |
HP:0010996 | HP:0012202 | Increased serum bile acid concentration | 2 | MYO5B CL E G H | 4645 | 7603 | OMIM:619868 | | | | | 192 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | NADK2 CL E G H | 133686 | 26404 | OMIM:616034 | 2,4-Dienoyl-Coa reductase deficiency | | | | 14 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | NADK2 CL E G H | 133686 | 26404 | ORPHA:431361 | Progressive encephalopathy with leukodystrophy due to DECR deficiency | HP:0040282 - Frequent | | | 14 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | NDUFAF6 CL E G H | 137682 | 28625 | ORPHA:3337 | Primary Fanconi renotubular syndrome | | | | 39 | | |
HP:0010996 | HP:0033418 | Elevated circulating 2-hydroxybutyric acid concentration | 2 | NFU1 CL E G H | 27247 | 16287 | OMIM:605711 | Multiple mitochondrial dysfunctions syndrome 1 | | | | 34 | | |
HP:0010996 | HP:0012202 | Increased serum bile acid concentration | 2 | NR1H4 CL E G H | 9971 | 7967 | ORPHA:69665 | Intrahepatic cholestasis of pregnancy | HP:0040281 - Very frequent | | | 14 | | |
HP:0010996 | HP:0034298 | Elevated circulating hexacosanoic acid concentration | 2 | PEX26 CL E G H | 55670 | 22965 | OMIM:614872 | Peroxisome biogenesis disorder 7A (zellweger) | | | | 106 | | |
HP:0010996 | HP:0034297 | Elevated circulating tetracosanoic acid concentration | 2 | PEX26 CL E G H | 55670 | 22965 | OMIM:614872 | Peroxisome biogenesis disorder 7A (zellweger) | | | | 106 | | |
HP:0010996 | HP:0012202 | Increased serum bile acid concentration | 2 | PKHD1 CL E G H | 5314 | 9016 | ORPHA:731 | Autosomal recessive polycystic kidney disease | HP:0040282 - Frequent | | | 563 | | |
HP:0010996 | HP:0012202 | Increased serum bile acid concentration | 2 | SBDS CL E G H | 51119 | 19440 | ORPHA:811 | Shwachman-Diamond syndrome | HP:0040282 - Frequent | | | 26 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | SCO1 CL E G H | 6341 | 10603 | OMIM:619048 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 4; MC4DN4 | | | | 46 | | |
HP:0010996 | HP:0012202 | Increased serum bile acid concentration | 2 | SEMA7A CL E G H | 8482 | 10741 | OMIM:619874 | | | | | 5 | | |
HP:0010996 | HP:0012202 | Increased serum bile acid concentration | 2 | SLC10A1 CL E G H | 6554 | 10905 | OMIM:619256 | HYPERCHOLANEMIA, FAMILIAL, 2; FHCA2 | | | | | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | SLC22A5 CL E G H | 6584 | 10969 | OMIM:212140 | Carnitine deficiency, systemic primary | | | | 207 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | SLC25A20 CL E G H | 788 | 1421 | ORPHA:159 | Carnitine-acylcarnitine translocase deficiency | | | | 40 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | SLC34A1 CL E G H | 6569 | 11019 | ORPHA:3337 | Primary Fanconi renotubular syndrome | | | | 47 | | |
HP:0010996 | HP:0030985 | Decreased serum bile acid concentration | 2 | SLC51B CL E G H | 123264 | 29956 | OMIM:619481 | BILE ACID MALABSORPTION, PRIMARY, 2; PBAM2 | | | | | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | SLC52A1 CL E G H | 55065 | 30225 | OMIM:615026 | Riboflavin deficiency | | | | 3 | | |
HP:0010996 | HP:0012202 | Increased serum bile acid concentration | 2 | SRP54 CL E G H | 6729 | 11301 | ORPHA:811 | Shwachman-Diamond syndrome | HP:0040282 - Frequent | | | | | |
HP:0010996 | HP:0012202 | Increased serum bile acid concentration | 2 | TALDO1 CL E G H | 6888 | 11559 | ORPHA:101028 | Transaldolase deficiency | HP:0040281 - Very frequent | | | 34 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | TANGO2 CL E G H | 128989 | 25439 | OMIM:616878 | Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration | | | | 12 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | TANGO2 CL E G H | 128989 | 25439 | ORPHA:480864 | Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome | | | | 12 | | |
HP:0010996 | HP:0012202 | Increased serum bile acid concentration | 2 | TJP2 CL E G H | 9414 | 11828 | OMIM:607748 | Hypercholanemia, familial | . | | | 149 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | TRMU CL E G H | 55687 | 25481 | ORPHA:254864 | Mitochondrial myopathy with reversible cytochrome C oxidase deficiency | | | | 101 | | |
HP:0010996 | HP:0010967 | Abnormal circulating carnitine concentration | 2 | TRNE CL E G H | 4556 | 7479 | ORPHA:254864 | Mitochondrial myopathy with reversible cytochrome C oxidase deficiency | | | | | | |
HP:0010996 | HP:0012202 | Increased serum bile acid concentration | 2 | UNC45A CL E G H | 55898 | 30594 | OMIM:619377 | OSTEOOTOHEPATOENTERIC SYNDROME; OOHE | | | | | | |
HP:0010996 | HP:0012202 | Increased serum bile acid concentration | 2 | VPS33B CL E G H | 26276 | 12712 | OMIM:620010 | | | | | 63 | | |
HP:0010996 | HP:0012202 | Increased serum bile acid concentration | 2 | VPS50 CL E G H | 55610 | 25956 | OMIM:619685 | NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND NEONATAL CHOLESTASIS; NEDMSC | | | | | | |
HP:0010996 | HP:0200150 | Increased serum bile acid concentration during pregnancy | 3 | ABCB4 CL E G H | 5244 | 45 | OMIM:614972 | Cholestasis, intrahepatic, of pregnancy 3 | . | | | 111 | | |
HP:0010996 | HP:0012071 | Abnormal circulating acetylcarnitine concentration | 3 | ABCD4 CL E G H | 5826 | 68 | OMIM:614857 | Methylmalonic aciduria and homocystinuria, Cblj type | | | | 53 | | |
HP:0010996 | HP:0012071 | Abnormal circulating acetylcarnitine concentration | 3 | ACAD8 CL E G H | 27034 | 87 | ORPHA:79159 | Isobutyryl-CoA dehydrogenase deficiency | | | | 58 | | |
HP:0010996 | HP:0003234 | Decreased plasma carnitine | 3 | ACAD8 CL E G H | 27034 | 87 | OMIM:611283 | Isobutyryl-CoA dehydrogenase deficiency | . | | | 58 | | |
HP:0010996 | HP:0003234 | Decreased plasma carnitine | 3 | ACAD8 CL E G H | 27034 | 87 | ORPHA:79159 | Isobutyryl-CoA dehydrogenase deficiency | HP:0040282 - Frequent | | | 58 | | |
HP:0010996 | HP:0012071 | Abnormal circulating acetylcarnitine concentration | 3 | ACAD9 CL E G H | 28976 | 21497 | ORPHA:99901 | Acyl-CoA dehydrogenase 9 deficiency | | | | 98 | | |
HP:0010996 | HP:0003234 | Decreased plasma carnitine | 3 | ACAD9 CL E G H | 28976 | 21497 | ORPHA:99901 | Acyl-CoA dehydrogenase 9 deficiency | HP:0040282 - Frequent | | | 98 | | |
HP:0010996 | HP:0003234 | Decreased plasma carnitine | 3 | ACADM CL E G H | 34 | 89 | OMIM:201450 | Acyl-Coa dehydrogenase, medium-chain, deficiency of | . | | | 197 | | |
HP:0010996 | HP:0003234 | Decreased plasma carnitine | 3 | ACADM CL E G H | 34 | 89 | ORPHA:42 | Medium chain acyl-CoA dehydrogenase deficiency | | | | 197 | | |
HP:0010996 | HP:0012071 | Abnormal circulating acetylcarnitine concentration | 3 | ACADS CL E G H | 35 | 90 | ORPHA:26792 | Short chain acyl-CoA dehydrogenase deficiency | | | | 90 | | |
HP:0010996 | HP:0003234 | Decreased plasma carnitine | 3 | ACADVL CL E G H | 37 | 92 | OMIM:201475 | Very long-chain acyl-CoA dehydrogenase deficiency | | | | 200 | | |
HP:0010996 | HP:0200150 | Increased serum bile acid concentration during pregnancy | 3 | ATP8B1 CL E G H | 5205 | 3706 | OMIM:147480 | Cholestasis, intrahepatic, of pregnancy, 1 | . | | | 144 | | |
HP:0010996 | HP:0003234 | Decreased plasma carnitine | 3 | COL7A1 CL E G H | 1294 | 2214 | ORPHA:89842 | Autosomal recessive generalized dystrophic epidermolysis bullosa, intermediate form | HP:0040282 - Frequent | | | 263 | | |
HP:0010996 | HP:0003234 | Decreased plasma carnitine | 3 | COL7A1 CL E G H | 1294 | 2214 | ORPHA:79408 | Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form | | | | 263 | | |
HP:0010996 | HP:0012071 | Abnormal circulating acetylcarnitine concentration | 3 | COX16 CL E G H | 51241 | 20213 | OMIM:619355 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 22; MC4DN22 | | | | | | |
HP:0010996 | HP:0012071 | Abnormal circulating acetylcarnitine concentration | 3 | CPT2 CL E G H | 1376 | 2330 | ORPHA:228302 | Carnitine palmitoyl transferase II deficiency, myopathic form | | | | 101 | | |
HP:0010996 | HP:0003234 | Decreased plasma carnitine | 3 | CPT2 CL E G H | 1376 | 2330 | ORPHA:228308 | Carnitine palmitoyl transferase II deficiency, neonatal form | | | | 101 | | |
HP:0010996 | HP:0012071 | Abnormal circulating acetylcarnitine concentration | 3 | CPT2 CL E G H | 1376 | 2330 | ORPHA:228308 | Carnitine palmitoyl transferase II deficiency, neonatal form | | | | 101 | | |
HP:0010996 | HP:0012071 | Abnormal circulating acetylcarnitine concentration | 3 | CPT2 CL E G H | 1376 | 2330 | ORPHA:228305 | Carnitine palmitoyl transferase II deficiency, severe infantile form | | | | 101 | | |
HP:0010996 | HP:0003234 | Decreased plasma carnitine | 3 | CPT2 CL E G H | 1376 | 2330 | ORPHA:228305 | Carnitine palmitoyl transferase II deficiency, severe infantile form | | | | 101 | | |
HP:0010996 | HP:0003234 | Decreased plasma carnitine | 3 | CPT2 CL E G H | 1376 | 2330 | OMIM:608836 | Carnitine palmitoyltransferase II deficiency, lethal neonatal | | | | 101 | | |
HP:0010996 | HP:0003234 | Decreased plasma carnitine | 3 | CTNS CL E G H | 1497 | 2518 | OMIM:219800 | Cystinosis, nephropathic | . | | | 178 | | |
HP:0010996 | HP:0003234 | Decreased plasma carnitine | 3 | DLD CL E G H | 1738 | 2898 | ORPHA:2394 | Pyruvate dehydrogenase E3 deficiency | HP:0040283 - Occasional | | | 89 | | |
HP:0010996 | HP:0003234 | Decreased plasma carnitine | 3 | EHHADH CL E G H | 1962 | 3247 | ORPHA:3337 | Primary Fanconi renotubular syndrome | HP:0040282 - Frequent | | | 2 | | |
HP:0010996 | HP:0012071 | Abnormal circulating acetylcarnitine concentration | 3 | ETHE1 CL E G H | 23474 | 23287 | OMIM:602473 | Encephalopathy, ethylmalonic | | | | 42 | | |
HP:0010996 | HP:0003234 | Decreased plasma carnitine | 3 | GATM CL E G H | 2628 | 4175 | ORPHA:3337 | Primary Fanconi renotubular syndrome | HP:0040282 - Frequent | | | 86 | | |
HP:0010996 | HP:0012071 | Abnormal circulating acetylcarnitine concentration | 3 | HADH CL E G H | 3033 | 4799 | ORPHA:71212 | Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency | HP:0040281 - Very frequent | | | 41 | | |
HP:0010996 | HP:0003234 | Decreased plasma carnitine | 3 | HADH CL E G H | 3033 | 4799 | ORPHA:71212 | Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency | HP:0040283 - Occasional | | | 41 | | |
HP:0010996 | HP:0012071 | Abnormal circulating acetylcarnitine concentration | 3 | HADHA CL E G H | 3030 | 4801 | OMIM:609015 | Mitochondrial trifunctional protein deficiency | | | | 99 | | |
HP:0010996 | HP:0012071 | Abnormal circulating acetylcarnitine concentration | 3 | HADHB CL E G H | 3032 | 4803 | OMIM:609015 | Mitochondrial trifunctional protein deficiency | | | | 60 | | |
HP:0010996 | HP:0003234 | Decreased plasma carnitine | 3 | HMGCL CL E G H | 3155 | 5005 | OMIM:246450 | 3-Hydroxy-3-Methylglutaryl-Coa lyase deficiency | . | | | 35 | | |
HP:0010996 | HP:0012071 | Abnormal circulating acetylcarnitine concentration | 3 | LMBRD1 CL E G H | 55788 | 23038 | ORPHA:79284 | Methylmalonic acidemia with homocystinuria type cblF | | | | 46 | | |
HP:0010996 | HP:0012071 | Abnormal circulating acetylcarnitine concentration | 3 | LMBRD1 CL E G H | 55788 | 23038 | OMIM:277380 | Methylmalonic aciduria and homocystinuria, Cblf type | | | | 46 | | |
HP:0010996 | HP:0003234 | Decreased plasma carnitine | 3 | MCCC2 CL E G H | 64087 | 6937 | OMIM:210210 | 3-Methylcrotonyl-CoA carboxylase 2 deficiency | | | | 77 | | |
HP:0010996 | HP:0012071 | Abnormal circulating acetylcarnitine concentration | 3 | MCEE CL E G H | 84693 | 16732 | OMIM:251120 | Methylmalonyl-Coa epimerase deficiency | | | | 19 | | |
HP:0010996 | HP:0012071 | Abnormal circulating acetylcarnitine concentration | 3 | MMACHC CL E G H | 25974 | 24525 | ORPHA:79282 | Methylmalonic acidemia with homocystinuria, type cblC | | | | 101 | | |
HP:0010996 | HP:0003234 | Decreased plasma carnitine | 3 | MMP1 CL E G H | 4312 | 7155 | ORPHA:79408 | Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form | | | | 6 | | |
HP:0010996 | HP:0003234 | Decreased plasma carnitine | 3 | NADK2 CL E G H | 133686 | 26404 | OMIM:616034 | 2,4-Dienoyl-Coa reductase deficiency | | | | 14 | | |
HP:0010996 | HP:0003234 | Decreased plasma carnitine | 3 | NADK2 CL E G H | 133686 | 26404 | ORPHA:431361 | Progressive encephalopathy with leukodystrophy due to DECR deficiency | HP:0040282 - Frequent | | | 14 | | |
HP:0010996 | HP:0003234 | Decreased plasma carnitine | 3 | NDUFAF6 CL E G H | 137682 | 28625 | ORPHA:3337 | Primary Fanconi renotubular syndrome | HP:0040282 - Frequent | | | 39 | | |
HP:0010996 | HP:0003234 | Decreased plasma carnitine | 3 | SCO1 CL E G H | 6341 | 10603 | OMIM:619048 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 4; MC4DN4 | | | | 46 | | |
HP:0010996 | HP:0003234 | Decreased plasma carnitine | 3 | SLC22A5 CL E G H | 6584 | 10969 | OMIM:212140 | Carnitine deficiency, systemic primary | . | | | 207 | | |
HP:0010996 | HP:0012071 | Abnormal circulating acetylcarnitine concentration | 3 | SLC25A20 CL E G H | 788 | 1421 | ORPHA:159 | Carnitine-acylcarnitine translocase deficiency | | | | 40 | | |
HP:0010996 | HP:0003234 | Decreased plasma carnitine | 3 | SLC25A20 CL E G H | 788 | 1421 | ORPHA:159 | Carnitine-acylcarnitine translocase deficiency | HP:0040281 - Very frequent | | | 40 | | |
HP:0010996 | HP:0003234 | Decreased plasma carnitine | 3 | SLC34A1 CL E G H | 6569 | 11019 | ORPHA:3337 | Primary Fanconi renotubular syndrome | HP:0040282 - Frequent | | | 47 | | |
HP:0010996 | HP:0034048 | Decreased circulating chenodeoxycholic acid concentration | 3 | SLC51B CL E G H | 123264 | 29956 | OMIM:619481 | BILE ACID MALABSORPTION, PRIMARY, 2; PBAM2 | | | | | | |
HP:0010996 | HP:0012071 | Abnormal circulating acetylcarnitine concentration | 3 | SLC52A1 CL E G H | 55065 | 30225 | OMIM:615026 | Riboflavin deficiency | | | | 3 | | |
HP:0010996 | HP:0012071 | Abnormal circulating acetylcarnitine concentration | 3 | TANGO2 CL E G H | 128989 | 25439 | OMIM:616878 | Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration | | | | 12 | | |
HP:0010996 | HP:0012071 | Abnormal circulating acetylcarnitine concentration | 3 | TANGO2 CL E G H | 128989 | 25439 | ORPHA:480864 | Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome | | | | 12 | | |
HP:0010996 | HP:0003234 | Decreased plasma carnitine | 3 | TRMU CL E G H | 55687 | 25481 | ORPHA:254864 | Mitochondrial myopathy with reversible cytochrome C oxidase deficiency | HP:0040283 - Occasional | | | 101 | | |
HP:0010996 | HP:0003234 | Decreased plasma carnitine | 3 | TRNE CL E G H | 4556 | 7479 | ORPHA:254864 | Mitochondrial myopathy with reversible cytochrome C oxidase deficiency | HP:0040283 - Occasional | | | | | |
HP:0010996 | HP:0033382 | Elevated circulating palmitoylcarnitine concentration | 4 | CL E G H | | | | | | | | | | |
HP:0010996 | HP:0033381 | Elevated circulating stearoylcarnitine concentration | 4 | CL E G H | | | | | | | | | | |
HP:0010996 | HP:0033445 | Reduced circulating acylcarnitine concentration | 4 | CL E G H | | | | | | | | | | |
HP:0010996 | HP:0033502 | Abnormal esterified to free carnitine ratio | 4 | CL E G H | | | | | | | | | | |
HP:0010996 | HP:0045045 | Elevated circulating acylcarnitine concentration | 4 | ABCD4 CL E G H | 5826 | 68 | OMIM:614857 | Methylmalonic aciduria and homocystinuria, Cblj type | | | | 53 | | |
HP:0010996 | HP:0045045 | Elevated circulating acylcarnitine concentration | 4 | ACAD8 CL E G H | 27034 | 87 | ORPHA:79159 | Isobutyryl-CoA dehydrogenase deficiency | HP:0040282 - Frequent | | | 58 | | |
HP:0010996 | HP:0045045 | Elevated circulating acylcarnitine concentration | 4 | ACAD9 CL E G H | 28976 | 21497 | ORPHA:99901 | Acyl-CoA dehydrogenase 9 deficiency | HP:0040282 - Frequent | | | 98 | | |
HP:0010996 | HP:0011936 | Decreased plasma total carnitine | 4 | ACADM CL E G H | 34 | 89 | ORPHA:42 | Medium chain acyl-CoA dehydrogenase deficiency | HP:0040282 - Frequent | | | 197 | | |
HP:0010996 | HP:0045045 | Elevated circulating acylcarnitine concentration | 4 | ACADS CL E G H | 35 | 90 | ORPHA:26792 | Short chain acyl-CoA dehydrogenase deficiency | HP:0040282 - Frequent | | | 90 | | |
HP:0010996 | HP:0011936 | Decreased plasma total carnitine | 4 | COL7A1 CL E G H | 1294 | 2214 | ORPHA:79408 | Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form | HP:0040283 - Occasional | | | 263 | | |
HP:0010996 | HP:0045045 | Elevated circulating acylcarnitine concentration | 4 | COX16 CL E G H | 51241 | 20213 | OMIM:619355 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 22; MC4DN22 | | | | | | |
HP:0010996 | HP:0045045 | Elevated circulating acylcarnitine concentration | 4 | CPT2 CL E G H | 1376 | 2330 | ORPHA:228302 | Carnitine palmitoyl transferase II deficiency, myopathic form | HP:0040282 - Frequent | | | 101 | | |
HP:0010996 | HP:0045045 | Elevated circulating acylcarnitine concentration | 4 | CPT2 CL E G H | 1376 | 2330 | ORPHA:228308 | Carnitine palmitoyl transferase II deficiency, neonatal form | HP:0040281 - Very frequent | | | 101 | | |
HP:0010996 | HP:0011936 | Decreased plasma total carnitine | 4 | CPT2 CL E G H | 1376 | 2330 | ORPHA:228308 | Carnitine palmitoyl transferase II deficiency, neonatal form | HP:0040281 - Very frequent | | | 101 | | |
HP:0010996 | HP:0008315 | Decreased plasma free carnitine | 4 | CPT2 CL E G H | 1376 | 2330 | ORPHA:228308 | Carnitine palmitoyl transferase II deficiency, neonatal form | HP:0040281 - Very frequent | | | 101 | | |
HP:0010996 | HP:0011936 | Decreased plasma total carnitine | 4 | CPT2 CL E G H | 1376 | 2330 | ORPHA:228305 | Carnitine palmitoyl transferase II deficiency, severe infantile form | HP:0040282 - Frequent | | | 101 | | |
HP:0010996 | HP:0008315 | Decreased plasma free carnitine | 4 | CPT2 CL E G H | 1376 | 2330 | ORPHA:228305 | Carnitine palmitoyl transferase II deficiency, severe infantile form | HP:0040282 - Frequent | | | 101 | | |
HP:0010996 | HP:0045045 | Elevated circulating acylcarnitine concentration | 4 | CPT2 CL E G H | 1376 | 2330 | ORPHA:228305 | Carnitine palmitoyl transferase II deficiency, severe infantile form | HP:0040282 - Frequent | | | 101 | | |
HP:0010996 | HP:0011936 | Decreased plasma total carnitine | 4 | CPT2 CL E G H | 1376 | 2330 | OMIM:608836 | Carnitine palmitoyltransferase II deficiency, lethal neonatal | . | | | 101 | | |
HP:0010996 | HP:0008315 | Decreased plasma free carnitine | 4 | CPT2 CL E G H | 1376 | 2330 | OMIM:608836 | Carnitine palmitoyltransferase II deficiency, lethal neonatal | . | | | 101 | | |
HP:0010996 | HP:0045045 | Elevated circulating acylcarnitine concentration | 4 | ETHE1 CL E G H | 23474 | 23287 | OMIM:602473 | Encephalopathy, ethylmalonic | | | | 42 | | |
HP:0010996 | HP:0045045 | Elevated circulating acylcarnitine concentration | 4 | HADHA CL E G H | 3030 | 4801 | OMIM:609015 | Mitochondrial trifunctional protein deficiency | | | | 99 | | |
HP:0010996 | HP:0045045 | Elevated circulating acylcarnitine concentration | 4 | HADHB CL E G H | 3032 | 4803 | OMIM:609015 | Mitochondrial trifunctional protein deficiency | | | | 60 | | |
HP:0010996 | HP:0045045 | Elevated circulating acylcarnitine concentration | 4 | LMBRD1 CL E G H | 55788 | 23038 | ORPHA:79284 | Methylmalonic acidemia with homocystinuria type cblF | | | | 46 | | |
HP:0010996 | HP:0045045 | Elevated circulating acylcarnitine concentration | 4 | LMBRD1 CL E G H | 55788 | 23038 | OMIM:277380 | Methylmalonic aciduria and homocystinuria, Cblf type | | | | 46 | | |
HP:0010996 | HP:0045045 | Elevated circulating acylcarnitine concentration | 4 | MCEE CL E G H | 84693 | 16732 | OMIM:251120 | Methylmalonyl-Coa epimerase deficiency | | | | 19 | | |
HP:0010996 | HP:0045045 | Elevated circulating acylcarnitine concentration | 4 | MMACHC CL E G H | 25974 | 24525 | ORPHA:79282 | Methylmalonic acidemia with homocystinuria, type cblC | | | | 101 | | |
HP:0010996 | HP:0011936 | Decreased plasma total carnitine | 4 | MMP1 CL E G H | 4312 | 7155 | ORPHA:79408 | Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form | HP:0040283 - Occasional | | | 6 | | |
HP:0010996 | HP:0008315 | Decreased plasma free carnitine | 4 | NADK2 CL E G H | 133686 | 26404 | OMIM:616034 | 2,4-Dienoyl-Coa reductase deficiency | . | | | 14 | | |
HP:0010996 | HP:0008315 | Decreased plasma free carnitine | 4 | SCO1 CL E G H | 6341 | 10603 | OMIM:619048 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 4; MC4DN4 | | | | 46 | | |
HP:0010996 | HP:0045045 | Elevated circulating acylcarnitine concentration | 4 | SLC25A20 CL E G H | 788 | 1421 | ORPHA:159 | Carnitine-acylcarnitine translocase deficiency | HP:0040281 - Very frequent | | | 40 | | |
HP:0010996 | HP:0045045 | Elevated circulating acylcarnitine concentration | 4 | SLC52A1 CL E G H | 55065 | 30225 | OMIM:615026 | Riboflavin deficiency | . | | | 3 | | |
HP:0010996 | HP:0045045 | Elevated circulating acylcarnitine concentration | 4 | TANGO2 CL E G H | 128989 | 25439 | OMIM:616878 | Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration | | | | 12 | | |
HP:0010996 | HP:0045045 | Elevated circulating acylcarnitine concentration | 4 | TANGO2 CL E G H | 128989 | 25439 | ORPHA:480864 | Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome | HP:0040283 - Occasional | | | 12 | | |
HP:0010996 | HP:0033440 | Elevated circulating octenoylcarnitine concentration | 5 | CL E G H | | | | | | | | | | |
HP:0010996 | HP:0033462 | Elevated circulating oleylcarnitine concentration | 5 | CL E G H | | | | | | | | | | |
HP:0010996 | HP:0033439 | Elevated circulating decenoylcarnitine concentration | 5 | CL E G H | | | | | | | | | | |
HP:0010996 | HP:0033461 | Elevated circulating 3-hydroxylinoleylcarnitine concentration | 5 | CL E G H | | | | | | | | | | |
HP:0010996 | HP:0033507 | Decreased esterified to free carnitine ratio | 5 | CL E G H | | | | | | | | | | |
HP:0010996 | HP:0033447 | Elevated circulating isovalerylcarnitine concentration | 5 | CL E G H | | | | | | | | | | |
HP:0010996 | HP:0033506 | Increased esterified to free carnitine ratio | 5 | CL E G H | | | | | | | | | | |
HP:0010996 | HP:0033442 | Elevated circulating glutarylcarnitine concentration | 5 | CL E G H | | | | | | | | | | |
HP:0010996 | HP:0033484 | Elevated circulating linoleylcarnitine concentration | 5 | CL E G H | | | | | | | | | | |
HP:0010996 | HP:0033441 | Elevated circulating hexanoylcarnitine concentration | 5 | CL E G H | | | | | | | | | | |
HP:0010996 | HP:0033464 | Elevated circulating 3-hydroxypalmitoleylcarnitine concentration | 5 | CL E G H | | | | | | | | | | |
HP:0010996 | HP:0033443 | Elevated circulating propionylcarnitine concentration | 5 | ABCD4 CL E G H | 5826 | 68 | OMIM:614857 | Methylmalonic aciduria and homocystinuria, Cblj type | | | | 53 | | |
HP:0010996 | HP:0033444 | Elevated circulating dodecanoylcarnitine concentration | 5 | COX16 CL E G H | 51241 | 20213 | OMIM:619355 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 22; MC4DN22 | | | | | | |
HP:0010996 | HP:0033465 | Elevated circulating tetradecanoylcarnitine concentration | 5 | COX16 CL E G H | 51241 | 20213 | OMIM:619355 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 22; MC4DN22 | | | | | | |
HP:0010996 | HP:0033446 | Elevated circulating butyrylcarnitine concentration | 5 | ETHE1 CL E G H | 23474 | 23287 | OMIM:602473 | Encephalopathy, ethylmalonic | | | | 42 | | |
HP:0010996 | HP:0031544 | Elevated circulating palmitoleylcarnitine concentration | 5 | LMBRD1 CL E G H | 55788 | 23038 | ORPHA:79284 | Methylmalonic acidemia with homocystinuria type cblF | HP:0040281 - Very frequent | | | 46 | | |
HP:0010996 | HP:0033443 | Elevated circulating propionylcarnitine concentration | 5 | LMBRD1 CL E G H | 55788 | 23038 | OMIM:277380 | Methylmalonic aciduria and homocystinuria, Cblf type | | | | 46 | | |
HP:0010996 | HP:0031544 | Elevated circulating palmitoleylcarnitine concentration | 5 | MCEE CL E G H | 84693 | 16732 | OMIM:251120 | Methylmalonyl-Coa epimerase deficiency | | | | 19 | | |
HP:0010996 | HP:0031544 | Elevated circulating palmitoleylcarnitine concentration | 5 | MMACHC CL E G H | 25974 | 24525 | ORPHA:79282 | Methylmalonic acidemia with homocystinuria, type cblC | HP:0040281 - Very frequent | | | 101 | | |